146 related articles for article (PubMed ID: 10052596)
21. [Effect of KSG-504, a new CCK-A-receptor antagonist, on experimental acute pancreatitis in rats and mice].
Kobayashi M; Shinagawa K; Sugiura M; Nagasawa T; Akahane M; Ajisawa Y
Nihon Yakurigaku Zasshi; 1996 Apr; 107(4):183-95. PubMed ID: 8690301
[TBL] [Abstract][Full Text] [Related]
22. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.
Vasar E; Stephenson JD; Meldrum BS
Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneous distribution of plasma membrane glycoconjugates in pancreatic acinar cells.
de Dios I; Uruñuela A; Sevillano S; de la Mano AM; Manso MA
Biochim Biophys Acta; 2000 Dec; 1509(1-2):292-8. PubMed ID: 11118540
[TBL] [Abstract][Full Text] [Related]
24. [Effect of KSG-504, a new synthetic cholecystokinin receptor antagonist on ethionine-induced acute pancreatitis in rats].
Okumura Y; Bamba T; Shintani Y; Yoshioka U; Inoue H; Fujiyama Y; Hosoda S
Nihon Shokakibyo Gakkai Zasshi; 1993 Dec; 90(12):3032-40. PubMed ID: 8283814
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of the lectin wheat germ agglutinin (WGA) on the proliferation of AR42J cells.
Ebert C; Nebe B; Walzel H; Weber H; Jonas L
Acta Histochem; 2009; 111(4):335-42. PubMed ID: 19195686
[TBL] [Abstract][Full Text] [Related]
26. Effect of L-364,718 (CCK receptor antagonist) on exocrine pancreatic secretion of hydrocortisone-treated rats.
De Dios I; Manso MA
Pancreas; 1994 Mar; 9(2):212-8. PubMed ID: 7514791
[TBL] [Abstract][Full Text] [Related]
27. Effects of the cholecystokinin receptor antagonist L-364,718 on pancreatitis induced by a deficient in choline and supplemented with ethionine (CDE) diet in the rat.
Manso MA; Rodriguez AI; Garcia-Montero AC; De Dios I
Arch Physiol Biochem; 1995 Aug; 103(4):410-5. PubMed ID: 8548474
[TBL] [Abstract][Full Text] [Related]
28. Cholecystokinin antagonist prevents hyperamylasemia and improves pancreatic exocrine function in cerulein-induced acute pancreatitis.
Murayama KM; Drew JB; Nahrwold DL; Joehl RJ
Pancreas; 1990 Jul; 5(4):439-44. PubMed ID: 1696383
[TBL] [Abstract][Full Text] [Related]
29. Involvement of endogenous cholecystokinin in pancreatic regeneration after cerulein-induced acute pancreatitis.
Jurkowska G; Grondin G; Morisset J
Pancreas; 1992; 7(3):295-304. PubMed ID: 1594550
[TBL] [Abstract][Full Text] [Related]
30. Early acinar cell changes in caerulein-induced interstitial acute pancreatitis in the rat.
Grönroos JM; Aho HJ; Hietaranta AJ; Nevalainen TJ
Exp Pathol; 1991; 41(1):21-30. PubMed ID: 2022252
[TBL] [Abstract][Full Text] [Related]
31. Effects of the cholecystokinin receptor antagonist L-364,718 on experimental pancreatitis in mice.
Silverman M; Ilardi C; Bank S; Kranz V; Lendvai S
Gastroenterology; 1989 Jan; 96(1):186-92. PubMed ID: 2462522
[TBL] [Abstract][Full Text] [Related]
32. Alteration of cholecystokinin receptor binding after caerulein-induced pancreatitis in rats.
Yazu T; Kimura T; Sumii T; Nawata H
Digestion; 1991; 50(3-4):142-8. PubMed ID: 1725866
[TBL] [Abstract][Full Text] [Related]
33. Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin.
Niederau C; Ferrell LD; Grendell JH
Gastroenterology; 1985 May; 88(5 Pt 1):1192-204. PubMed ID: 2984080
[TBL] [Abstract][Full Text] [Related]
34. Cholecystokinin blockade triggers earlier and enhanced intra-acinar oxygen free radical generation in acute pancreatitis induced by pancreatic duct obstruction in rats.
Uruñuela A; Manso MA; de la Mano AM; de Dios I
Clin Sci (Lond); 2003 Aug; 105(2):203-12. PubMed ID: 12713440
[TBL] [Abstract][Full Text] [Related]
35. Adrenalectomy induces a decrease in the light scatter properties and amylase content of isolated zymogen granules from rat pancreas as analyzed by flow cytometry.
Garcia-Montero AC; De Dios I; Rodriguez AI; Orfao A; Manso MA
J Endocrinol; 1995 Dec; 147(3):431-40. PubMed ID: 8543913
[TBL] [Abstract][Full Text] [Related]
36. Cholecystokinin augmentation of 'surgical' pancreatitis. Benefits of receptor blockade.
Modlin IM; Bilchik AJ; Zucker KA; Adrian TE; Sussman J; Graham SM
Arch Surg; 1989 May; 124(5):574-8. PubMed ID: 2469410
[TBL] [Abstract][Full Text] [Related]
37. Role of cholecystokinin in the development and progression of acute pancreatitis and the potential of therapeutic application of cholecystokinin receptor antagonists.
Niederau C; Grendell JH
Digestion; 1999; 60 Suppl 1():69-74. PubMed ID: 10026436
[TBL] [Abstract][Full Text] [Related]
38. Low enzyme content in the pancreas does not reduce the severity of acute pancreatitis induced by bile-pancreatic duct obstruction.
De La Mano A; Sevillano S; De Dios I; Vicente S; Manso MA
Mol Cell Biochem; 2002 Nov; 240(1-2):75-81. PubMed ID: 12487374
[TBL] [Abstract][Full Text] [Related]
39. Early development of experimental biliary pancreatitis and its amelioration by CCK-receptor blockade.
Niederau C; Borchard F; Lüthen R; Niederau M
Hepatogastroenterology; 1996; 43(12):1442-53. PubMed ID: 8975946
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vivo.
Taniguchi H; Yazaki N; Yomota E; Shikano T; Endo T; Nagasaki M
Eur J Pharmacol; 1996 Sep; 312(2):227-33. PubMed ID: 8894600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
